Position papers
AIM recommendations on Vaccine Hesitancy
Vaccination is one of the most successful and cost-effective interventions to improve health outcomes. While it is true that no vaccine is 100% effective, high uptake rates have allowed to eliminate,......
What payers think about the latest HTA proposal
AIM welcomes efforts at EU level to improve the quality and timeliness of health technology assessments. It is excellent to ensure through Union-wide collaboration that the assessor has timely access......
AIM publishes position on TFAs
AIM answered the open public consultation on the initiative to limit industrial trans fats intakes in the EU. On that occasion the organisation also published a position paper: TFApositionpaper as......
AIM members have different roles in ensuring access to pharmaceuticals
AIM discusses during its general assembly in Rome in November 2017 what could be appropriate steps towards sustainable access to pharmaceuticals. But why should AIM members be involved in those discus......
We know what FAIR is!
The Dutch Minister of Health, Mrs Edith Schippers, brought the topic to the agenda of the European Council last year. The Commission is now trying to find out whether she had a point, whether it is tr......
Press release: Dialogue between EMA and AIM
The AIM Working Group on Pharmaceuticals participated last week in London, at the European Medicines Agency (EMA) in a dialogue between EMA and payer organisations about how to ensure alignment of eff......